|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.89 DKK | +0.88% |
|
+1.13% | +8.71% |
| 12-03 | BNP Paribas Exane Raises Price Target for Lundbeck to 45 Danish Kroner, Reiterates Neutral Rating - BN | FW |
| 12-02 | H. Lundbeck A/S Presents Comprehensive New Bexicaserin Dataset Epilepsies | CI |
| Capitalization | 42.14B 6.58B 5.64B 5.27B 4.93B 9.17B 591B 9.94B 61.88B 23.88B 279B 24.69B 24.16B 1,018B | P/E ratio 2025 * |
11.3x | P/E ratio 2026 * | 10.1x |
|---|---|---|---|---|---|
| Enterprise value | 50.82B 7.93B 6.8B 6.36B 5.94B 11.06B 713B 11.98B 74.63B 28.8B 337B 29.77B 29.14B 1,228B | EV / Sales 2025 * |
2.07x | EV / Sales 2026 * | 1.85x |
| Free-Float |
30.74% | Yield 2025 * |
2.81% | Yield 2026 * | 3.1% |
Last Transcript: H. Lundbeck A/S
| 1 day | +0.88% | ||
| 1 week | +1.13% | ||
| Current month | +1.13% | ||
| 1 month | -2.56% | ||
| 3 months | +8.40% | ||
| 6 months | +16.98% | ||
| Current year | +8.71% |
| 1 week | 43.68 | 44.94 | |
| 1 month | 42.56 | 47.16 | |
| Current year | 27.2 | 47.78 | |
| 1 year | 27.2 | 47.78 | |
| 3 years | 25.12 | 49.38 | |
| 5 years | 23.3 | 49.38 | |
| 10 years | 23.3 | 49.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charl van Zyl
CEO | Chief Executive Officer | 58 | 2023-09-30 |
Jörg Hornstein
DFI | Director of Finance/CFO | 48 | 2022-08-31 |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 66 | 2015-03-24 | |
| Director/Board Member | 66 | 2015-03-24 | |
| Director/Board Member | 59 | 2018-03-19 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.88% | +1.13% | +1.31% | +66.80% | 6.58B | ||
| +1.09% | -7.87% | +33.04% | +110.46% | 100B | ||
| -0.26% | -6.54% | +59.05% | +146.28% | 47.33B | ||
| +3.26% | -1.04% | - | - | 21.01B | ||
| -0.40% | +2.62% | +14.08% | +1.70% | 10.49B | ||
| -0.22% | +0.45% | -16.28% | -6.19% | 8.48B | ||
| +0.49% | +2.59% | +0.29% | +10.42% | 8.2B | ||
| +0.24% | +1.10% | +21.65% | +28.97% | 5.72B | ||
| -2.63% | -2.75% | +10.23% | +52.91% | 3.6B | ||
| +0.40% | +3.25% | -4.15% | +0.07% | 3.58B | ||
| Average | +0.22% | -0.97% | +13.24% | +45.72% | 21.55B | |
| Weighted average by Cap. | +0.45% | -5.31% | +32.30% | +97.03% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 24.53B 3.83B 3.28B 3.07B 2.87B 5.34B 344B 5.78B 36.02B 13.9B 162B 14.37B 14.06B 592B | 25.18B 3.93B 3.37B 3.15B 2.94B 5.48B 353B 5.94B 36.97B 14.27B 167B 14.75B 14.43B 608B |
| Net income | 3.89B 607M 521M 487M 455M 847M 54.56B 918M 5.71B 2.21B 25.78B 2.28B 2.23B 94.01B | 4.36B 681M 584M 546M 510M 950M 61.19B 1.03B 6.41B 2.47B 28.91B 2.56B 2.5B 105B |
| Net Debt | 8.68B 1.35B 1.16B 1.09B 1.01B 1.89B 122B 2.05B 12.75B 4.92B 57.51B 5.09B 4.98B 210B | 4.47B 698M 599M 560M 523M 973M 62.7B 1.05B 6.57B 2.53B 29.62B 2.62B 2.56B 108B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-05 | 44.92 kr | +0.94% | 145,580 |
| 25-12-04 | 44.50 kr | +1.09% | 228,263 |
| 25-12-03 | 44.02 kr | -0.68% | 332,435 |
| 25-12-02 | 44.32 kr | +1.23% | 294,344 |
| 25-12-01 | 43.78 kr | -1.44% | 578,739 |
Delayed Quote Nasdaq Copenhagen, December 05, 2025 at 09:12 am
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HLUN B Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition


















